Scinovex
article Open Access

Parenteral tranexamic acid reduces postoperative blood loss and transfusion rates after total knee arthroplasty: A prospective randomized controlled trial

National Journal of Clinical Orthopaedics · 2019 · Vol. 3(4) · pp. 20–24
Sibin SurendranRaju KaruppalAnwar Marthya

Abstract

Background: TKA has been considered one of the most successful surgeries in orthopedics. Blood loss related to total knee arthroplasty has been a topic of concern. Post operative blood transfusion carries imminent risk of disease transmission, febrile reactions and involves additional cost. It is advisable to avoid blood transfusion in the postoperative cases whenever possible. Many strategies are used to reduce postoperative blood loss like intraoperative tourniquet, cell savers and preoperative hemoglobin raising agents. Drugs like Tranexamic acid (TA) that inhibit the fibrinolytic system may be used to reduce the intraoperative and postoperative blood loss. Inhibition of fibrinolysis may increase the chances of thromboembolic disease. We studied the efficacy of parenteral tranexamic acid (TA) in reducing the postoperative blood loss and blood transfusion requirements and its impact on incidence of DVT in the postoperative period after TKA. Patients and Methods: We did a prospective, randomised, double blind study on 130 patients who underwent primary unilateral cemented total knee arthroplasty between May 2016 and May 2017 at our institution. Patients were randomized into two groups: the study group received tranexamic acid intravenously (15 mg/kg) 10 minutes before inflation of the tourniquet and 3 hours postoperatively while the control group received a similar volume of normal saline (placebo) at similar timings. We measured the reduction in hemoglobin levels at 24 hours postoperatively, total volume of blood drained at 24 hours postoperatively, amount of blood transfused, and number of patients requiring allogenic blood transfusion in the initial two days of surgery. All patients were screened for DVT with duplex ultrasound assessment of both legs on the third post-operative day. The minimum follow up was 6 months (mean, 10.4 months; range, 6–12 months).Results: We found a statistically significant (p

Blood transfusion and managementVenous Thromboembolism Diagnosis and ManagementTotal Knee Arthroplasty OutcomesMedicineTranexamic acidTourniquetAnesthesiaSurgeryBlood transfusionSalineArthroplastyBlood volumeTotal knee arthroplasty
Citations
0
FWCI
0.00
field-weighted impact
References
31
Percentile
9%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Parenteral tranexamic acid reduces postoperative blood loss and transfusion rates after total knee arthroplasty: A prospective randomized controlled trial · Scinovex